文献速递临床试验与 GCP

静脉利多卡因对丙泊酚镇静下胃肠镜操作所致低氧血症的影响:前瞻性随机对照试验研究方案

Effects of intravenous lidocaine on hypoxemia induced by propofol-based sedation for gastrointestinal endoscopy procedures: study protocol for a prospective, randomized, controlled trial.
PubMed 文献 · Trials · 2022-09-24

该研究为单中心、前瞻性、随机、双盲、生理盐水对照试验,计划纳入300例接受无痛胃肠镜操作的患者,随机分为利多卡因组(L组)和对照组(C组)。利多卡因组在静脉注射咪达唑仑和舒芬太尼后,立即给予1.5 mg/kg利多卡因负荷量,随后以4 mg/kg/h持续输注;对照组给予等容量生理盐水。主要结局为氧饱和度下降事件的发生率,次要结局包括不自主体动、不适症状、丙泊酚用量、内镜医师及患者满意度。

要点

  • 利多卡因组给予1.5 mg/kg负荷量后4 mg/kg/h持续输注,对照组给予等容量生理盐水。
  • 主要结局为氧饱和度下降事件的发生率,次要结局包括不自主体动和丙泊酚用量等。
  • 该试验为单中心、前瞻性、随机、双盲、生理盐水对照设计,计划纳入300例患者。

核心结论

  • 该研究旨在评估静脉利多卡因在丙泊酚镇静下胃肠镜操作中的有效性和安全性,期望评估利多卡因对减少氧饱和度下降事件、心血管事件和不自主体动发生率的作用。

研究设计与样本

  • 单中心、前瞻性、随机、双盲、生理盐水对照试验,计划纳入300例接受无痛胃肠镜操作的患者,随机分为利多卡因组(L组)和对照组(C组)。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 利多卡因组在静脉注射咪达唑仑和舒芬太尼后,立即给予1.5 mg/kg利多卡因负荷量,随后以4 mg/kg/h持续输注;对照组给予等容量生理盐水。
  • 主要结局为氧饱和度下降事件的发生率;次要结局为不自主体动、不适症状、丙泊酚用量、内镜医师及患者满意度的发生率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oxygen-desaturation episodes, blood pressure drops, and involuntary body movement are common problems that occur in propofol-based sedation in the procedure of painless gastrointestinal (GI) endoscopy. As a widely used analgesic adjuvant, intravenous lidocaine can reduce the consumption of propofol during ERCP or colonoscopy. However, it is still unknown how lidocaine affects the incidence of oxygen-desaturation episodes and cardiovascular events, and involuntary movement during painless GI endoscopy. Therefore, we aimed to assess the effectiveness and safety of intravenous lidocaine in propofol-based sedation for GI endoscopy. METHODS: We will conduct a single-center, prospective, randomized, double-blind, saline-controlled trial. A total number of 300 patients undergoing painless GI procedures will be enrolled and randomly divided into the lidocaine group (Group L) and the control group (Group C). After midazolam and sufentanil intravenous injection, a bolus of 1.5 mg/kg lidocaine was immediately injected and followed by a continuous infusion of 4 mg/kg/h in the lidocaine group, whereas the same volumes of saline solution in the control group. Then, propofol was titrated to produce unconsciousness during the procedure. The primary outcome will be the incidence of oxygen-desaturation episodes. Secondary outcomes will be the incidence of involuntary body movement, discomfort symptoms, propofol consumption, endoscopist, and patient satisfaction. DISCUSSION: Propofol-based deep sedation without intubation is widely used in painless GI endoscopy. However, adverse events such as hypoxemia often occur clinically. We expect to assess the effect of lidocaine on reducing the incidence of oxygen-desaturation episodes, cardiovascular events, and involuntary body movement. We believe that the results of this trial will provide an effective and safe method for painless GI endoscopy. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100053818. Registered on 30 November 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Qi XR, Sun JY, An LX, et al. Effects of intravenous lidocaine on hypoxemia induced by propofol-based sedation for gastrointestinal endoscopy procedures: study protocol for a prospective, randomized, controlled trial. Trials. 2022. PMID: 36153625. doi:10.1186/s13063-022-06719-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。